[1] Phase I study of intravenous ribavirin treatment of respiratory syncytial virus pneumonia after marrow transplantation

[2] Dengue infection associated hemophagocytic syndrome: Therapeutic interventions and outcome

[3] Predictors of mortality in severe malaria: a two year experience in a non-endemic area

[4] The course, costs and complications of oral versus intravenous penicillin therapy of erysipelas

[5] Hyperimmune globulins in prevention and treatment of respiratory syncytial virus infections

[6] The prevalence of hepatitis C virus infection in the United States, 1999 through 2002

[7] Oral versus intravenous empirical antimicrobial therapy for fever in patients with granulocytopenia who are receiving cancer chemotherapy. International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer

[8] The safety and efficacy of daptomycin for the treatment of complicated skin and skin-structure infections

[9] Levofloxacin cures experimental pneumonic plague in African green monkeys

[10] Intravenous immunoglobulin G therapy in streptococcal toxic shock syndrome: a European randomized, double-blind, placebo-controlled trial

[11] Risk factors for Clostridium difficile toxin-associated diarrhea

[12] Population-based community prevalence of methicillin-resistant Staphylococcus aureus in the urban poor of San Francisco

[13] Dietary restriction increases insulin sensitivity and lowers blood glucose in rhesus monkeys

[14] Controlled trial to evaluate protection of high-risk infants against respiratory syncytial virus disease by using standard intravenous immune globulin

[15] prospective study on the effect of omega-3 fish oil emulsion on inflammatory responses, immune function, and prognosis in patients with liver transplantation

[16] anestesia en la operación de blalock-taussig

[17] treatment of chronic hepatitis c among injecting drug users: a 5-year follow-up

[18] efeitos do tratamento prévio com lidocaína, paracetamol e lidocaína-fentanil por via venosa na dor causada pela injeção de propofol: estudo comparativo efectos del tratamiento previo con lidocaína, paracetamol y lidocaína-fentanil intravenosos en el dolor causado por la inyección de propofol: estudio comparativo effect of pretreatment with lidocaine, intravenous paracetamol and lidocaine-fentanyl on propofol injection pain: comparative study

[19]

[20] incidence and risk factors of postoperative residual curarization in patients with breast cancer: prospective cohort study

[21] tratamento de vasculopatia livedóide com imunoglobulina intravenosa treatment of livedoid vasculopathy with intravenous immunoglobulin

[22] Effect of physical exercise on sensitivity and responsiveness to insulin in humans

[23] The calcium sensitizer levosimendan and cardiac arrhythmias: an analysis of the safety database of heart failure treatment studies

[24] Efficacy and safety of the pulsed infusions of levosimendan in outpatients with advanced heart failure (LevoRep) study: a multicentre randomized trial

[25] Clinicians' Views of Hepatitis C Virus Treatment Candidacy With Direct-Acting Antiviral Regimens for People Who Inject Drugs

[26] MRI findings in Tolosa-Hunt syndrome before and after systemic corticosteroid therapy

[27] Recurrent neonatal sepsis and progressive white matter injury in a premature newborn culture-positive for group B Streptococcus: A case report

[28] Pharmacokinetics of zanamivir after intravenous, oral, inhaled or intranasal administration to healthy volunteers

[29] Effect of levosimendan on estimated glomerular filtration rate in hospitalized patients with decompensated heart failure and renal dysfunction

[30] Group B streptococci: results of a protocol of antepartum screening and intrapartum treatment

[31] Magnesium sulphate versus diazepam for eclampsia

[32] Haemodynamic effects of levosimendan in advanced but stable chronic heart failure

[33] Predictors of insufficient amikacin peak concentration in critically ill patients receiving a 25 mg/kg total body weight regimen

[34] Antitoxin levels in botulism patients treated with trivalent equine botulism antitoxin to toxin types A, B, and E

[35] Randomised controlled trial of intravenous antibiotic treatment for cellulitis at home compared with hospital

[36] Autologous haematopoietic stem-cell transplantation versus bortezomib-melphalan-prednisone, with or without bortezomib-lenalidomide-dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study

[37] Comparative disposition of dimethylaminoethanol and choline in rats and mice following oral or intravenous administration.

[38] Oral sitafloxacin vs intravenous ceftriaxone followed by oral cefdinir for acute pyelonephritis and complicated urinary tract infection: a randomized controlled trial

[39] Emerging treatment options for acute bacterial skin and skin structure infections: focus on intravenous delafloxacin

[40] Efficacy of intravenous tigecycline in patients with Acinetobacter complex infections: results from 14 Phase III and Phase IV clinical trials

[41] Mycotic pseudoaneurysm in intravenous drug users: current insights

[42] Gastric Siderosis and Ulceration from Intravenous Iron Supplementation Manifesting as Chronic Upper Gastrointestinal Bleeding: A Case Report and Review of the Literature

[43] Oral sitafloxacin vs intravenous ceftriaxone followed by oral cefdinir for acute pyelonephritis and complicated urinary tract infection: a randomized controlled trial

[44] Emerging treatment options for acute bacterial skin and skin structure infections: focus on intravenous delafloxacin

[45] Successful Treatment of Sjögren’s Syndrome Presenting as a Condition Similar to Chronic Capillary Leak Syndrome Using Combination Therapy with High-Dose Intravenous Immunoglobulin and Glucocorticoid

[46] Is Subcutaneous Route an Alternative to Intravenous Route for Mouse Contrast-Enhanced Magnetic Resonance Imaging at 1.5 T?

[47] Efficacy of intravenous tigecycline in patients with Acinetobacter complex infections: results from 14 Phase III and Phase IV clinical trials

[48] Mycotic pseudoaneurysm in intravenous drug users: current insights

[49] Intravenous morphine versus intravenous paracetamol after cardiac surgery in neonates and infants: a study protocol for a randomized controlled trial

[50] Rail-roading technique using 18 gauge intravenous catheter and silicon rod for frontalis suspension in blepharophimosis syndrome.

[51] Remifentanil-Sparing Effect of Pectoral Nerve Block Type II in Breast Surgery under Surgical Pleth Index-Guided Analgesia during Total Intravenous Anesthesia.

[52] Phase 2 trial of weekly intravenous 1,25 dihydroxy cholecalciferol (calcitriol) in combination with dexamethasone for castration-resistant prostate cancer

[53] Development of an intravenous drug manual for a critical care satellite pharmacy.

[54] Limited Sampling Strategies Supporting Individualized Dose Adjustment of Intravenous Busulfan in Children and Young Adults.

[55] [Successful treatment of post circumcision glanular ischemia-necrosis with hyperbaric oxygen and intravenous pentoxifylline].

[56] IL15 by continuous intravenous infusion to adult patients with solid tumors in a phase I trial induced dramatic NK-cell subset expansion

[57] Chemotherapy intravenously in children with cancer at home, the nurse practitioner makes it possible!

[58] Anemia and leukopenia following intravenous colloidal silver infusions-Clinical and hematological features, unique peripheral blood film appearance and effective therapy with supplemental oral copper and apheresis.

[59] Efficacy of intratympanic corticosteroid, intravenous batroxobin and combined treatment for sudden sensorineural hearing loss with type-2 diabetes

[60] Cost Minimization Analysis of Intravenous or Subcutaneous Trastuzumab Treatment in Patients With HER2-Positive Breast Cancer in Ireland.

[61] Pharmacokinetic properties of ethosuximide in monkeys. I. Single-dose intravenous and oral administration.

[62] Desarrollo tecnológico de sulfato de cinc 5 mg/mL infusión intravenosa Technological development of zinc sulphate 5 mg/mL intravenous infusion

[63] Comparison of Topical and Intravenous Tranexamic Acid for Total Knee Replacement: A Randomized Double-Blinded Controlled Study of Effects on Tranexamic Acid Levels and Thrombogenic and Inflammatory Marker Levels.

[64] Time to relapse after a single administration of intravenous ketamine augmentation in unipolar treatment-resistant depression

[65] Highly variable pharmacokinetics of once-daily intravenous busulfan when combined with fludarabine in pediatric patients: phase I clinical study for determination of optimal once-daily busulfan dose using pharmacokinetic modeling.

[66] Accurate targeting of daily intravenous busulfan with 8-hour blood sampling in hospitalized adult hematopoietic cell transplant recipients.

[67] Kounis syndrome presenting with acute inferior wall myocardial infarction and cardiogenic shock secondary to intravenous ampicillin/sulbactam administration.

[68] Prevention of tuberculosis in macaques after intravenous BCG immunization.

[69] Nurses as a source of system-level resilience: Secondary analysis of qualitative data from a study of intravenous infusion safety in English hospitals

[70] Safety and Outcomes of Intravenous tPA in Acute Ischemic Stroke Patients With Prior Stroke Within 3 Months: Findings From Get With The Guidelines-Stroke

[71] Community IntraVenous Antibiotic Study (CIVAS): protocol for an evaluation of patient preferences for and cost-effectiveness of community intravenous antibiotic services.

[72] The Community IntraVenous Antibiotic Study (CIVAS): a mixed-methods evaluation of patient preferences for and cost-effectiveness of different service models for delivering outpatient parenteral antimicrobial therapy

[73] Effectiveness of Intravenous Isoniazid and Ethambutol Administration in Patients with Tuberculosis Meningoencephalitis and HIV Infection.

[74] Trend and Economic Burden of Intravenous Narcotic Analgesic Utilization in Major Vascular Interventions in the United States.

[75] Validation of RP-HPLC method to assess the compatibility of metoclopramide and midazolam intravenous mixture used in patients with cancer.

[76] Effects of intravenous injection of indocyanine green on the oxygen reserve index (ORi™).

[77] CSF omeprazole concentration and albumin quotient following high dose intravenous omeprazole in dogs.

[78] Higher Optimization of Pharmacokinetic and Pharmacodynamic Parameters Through Loading Dose of Intravenous Colistin in Pediatric Patients.

[79] Oligopeptide-modified poly(beta-amino ester)s-coated AdNuPARmE1A: Boosting the efficacy of intravenously administered therapeutic adenoviruses.

[80] Evaluation of the efficacy and safety of intravenous remdesivir in adult patients with severe COVID-19: study protocol for a phase 3 randomized, double-blind, placebo-controlled, multicentre trial

[81] Safety of Intravenous Infusion of Doripenem

[82] Erratum to: Efficacy and Safety of Intravenous-to-oral Lefamulin, a Pleuromutilin Antibiotic, for the Treatment of Community-acquired Bacterial Pneumonia: The Phase III Lefamulin Evaluation Against Pneumonia (LEAP 1) Trial

[83] Respiratory syncytial virus upper respiratory tract illnesses in adult blood and marrow transplant recipients: combination therapy with aerosolized ribavirin and intravenous immunoglobulin

[84] A Randomized Controlled Trial of Intravenous N-acetylcysteine in the Management of Anti-tuberculosis Drug-Induced Liver Injury

[85] Rare Complications With Intravenous Hyperosmotic Alimentation

[86] Antiplatelet Antibodies Do Not Predict the Response to Intravenous Immunoglobulins during Immune Thrombocytopenia

[87] Mycobacterium abscessus Bacteremia After Receipt of Intravenous Infusate of Cytokine-Induced Killer Cell Therapy for Body Beautification and Health Boosting

[88] Phase I study of intravenous ribavirin treatment of respiratory syncytial virus pneumonia after marrow transplantation.

[89] Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients

[90] Phase I study of intravenous ribavirin treatment of respiratory syncytial virus pneumonia after marrow transplantation

[91] Rare complications with intravenous hyperosmotic alimentation

[92] Respiratory syncytial virus upper respiratory tract illnesses in adult blood and marrow transplant recipients: combination therapy with aerosolized ribavirin and intravenous immunoglobulin

[93] The course, costs and complications of oral versus intravenous penicillin therapy of erysipelas

[94] Oral versus intravenous empirical antimicrobial therapy for fever in patients with granulocytopenia who are receiving cancer chemotherapy. International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer

[95] Efficacy of Intravenous Infusion of Doripenem

[96] Oral moxifloxacin or intravenous ceftriaxone for the treatment of low-risk neutropenic fever in cancer patients suitable for early hospital discharge

[97] Efficacy and Safety of Intravenous-to-oral Lefamulin, a Pleuromutilin Antibiotic, for the Treatment of Community-acquired Bacterial Pneumonia: The Phase III Lefamulin Evaluation Against Pneumonia (LEAP 1) Trial

[98] The course, costs and complications of oral versus intravenous penicillin therapy of erysipelas

[99] Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients.

[100] Respiratory syncytial virus (RSV) immune globulin intravenous therapy for RSV lower respiratory tract infection in infants and young children at high risk for severe RSV infections: Respiratory Syncytial Virus Immune Globulin Study Group

[101] Controlled trial to evaluate protection of high-risk infants against respiratory syncytial virus disease by using standard intravenous immune globulin